Prostate cancer disparities among American Indians and Alaskan Natives in the United States

Author:

Chu Carissa E1ORCID,Leapman Michael S2,Zhao Shoujun3,Cowan Janet E3,Washington Samuel L3,Cooperberg Matthew R34ORCID

Affiliation:

1. Urology Service, Memorial Sloan Kettering Cancer Center , New York, NY, USA

2. Department of Urology, Yale University , New Haven, CT, USA

3. Department of Urology, Helen Diller Family Comprehensive Cancer Center, University of California , San Francisco, CA, USA

4. Department of Epidemiology and Biostatistics, University of California , San Francisco, CA, USA

Abstract

AbstractBackgroundAmericans Indians and Alaska Natives face disparities in cancer care with lower rates of screening, limited treatment access, and worse survival. Prostate cancer treatment access and patterns of care remain unknown.MethodsWe used Surveillance, Epidemiology, and End Results data to compare incidence, primary treatment, and cancer-specific mortality across American Indian and Alaska Native, Asian and Pacific Islander, Black, and White patients. Baseline characteristics included prostate-specific antigen (PSA), Gleason score (GS), tumor stage, 9-level Cancer of the Prostate Risk Assessment risk score, county characteristics, and health-care provider density. Primary outcomes were first definitive treatment and prostate cancer-specific mortality (PCSM).ResultsAmerican Indian and Alaska Native patients were more frequently diagnosed with higher PSA, GS greater than or equal or 8, stage greater than or equal to cT3, high-risk disease overall (Cancer of the Prostate Risk Assessment risk score ≥ 6), and metastases at diagnosis than any other group. Adjusting for age, PSA, GS, and clinical stage, American Indian or Alaska Native patients with localized prostate cancer were more likely to undergo external beam radiation than radical prostatectomy and had the highest rates of no documented treatment. Five-year PCSM was higher among American Indian and Alaska Natives than any other racial group. However, after multivariable adjustment accounting for clinical and pathologic factors, county-level demographics, and provider density, American Indian and Alaska Native patient PCSM hazards were no different than those of White patients.ConclusionsAmerican Indian or Alaska Native patients have more advanced prostate cancer, lower rates of definitive treatment, higher mortality, and reside in areas of less specialty care. Disparities in access appear to account for excess risks of PCSM. Focused health policy interventions are needed to address these disparities.

Funder

AstraZeneca

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Reference24 articles.

1. Cancer screening in Native Americans from the Northern Plains;Pandhi;Am J Prev Med,2010

2. Prostate cancer screening among American Indians and Alaska Natives: The Health and Retirement Survey, 1996-2008;Goins;Prevent Chronic Dis,2015

3. Cancer survival among US Whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study;Clegg;Arch Intern Med,2002

4. Cancer treatment delays in American Indians and Alaska Natives enrolled in Medicare;Adams;J Health Care Poor Underserved,2017

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3